OneAscent Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-412
Closed -$223K 181
2024
Q2
$223K Sell
412
-163
-28% -$86.2K 0.12% 90
2024
Q1
$298K Sell
575
-5
-0.9% -$2.49K 0.11% 128
2023
Q4
$274K Sell
580
-34
-6% -$15.7K 0.11% 131
2023
Q3
$267K Buy
+614
New +$278K 0.12% 122
2023
Q2
Sell
-735
Closed -$338K 132
2023
Q1
$338K Sell
735
-117
-14% -$55.7K 0.13% 107
2022
Q4
$437K Sell
852
-203
-19% -$103K 0.21% 59
2022
Q3
$479K Buy
1,055
+117
+12% +$56K 0.25% 40
2022
Q2
$453K Sell
938
-64
-6% -$31.7K 0.23% 61
2022
Q1
$492K Sell
1,002
-83
-8% -$37.9K 0.25% 80
2021
Q4
$503K Buy
+1,085
New +$456K 1.26% 27
2021
Q1
$1.14M Buy
+3,181
New +$1.02M 0.49% 33

Other funds holding ELV

OneAscent Wealth Management's ELV Position: Q3 2024 in Review

OneAscent Wealth Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 412 shares — an estimated $223K sold.

OneAscent Wealth Management first reported a position in ELV in Q1 2021 and held it in 11 quarters. The position peaked at $1.14M in Q1 2021. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • OneAscent Wealth Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • OneAscent Wealth Management sold 412 Elevance Health shares in Q3 2024, an estimated $223K.
  • OneAscent Wealth Management first reported a position in Elevance Health in Q1 2021 and held it in 11 quarters.
  • OneAscent Wealth Management's Elevance Health position peaked at $1.14M in Q1 2021.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on OneAscent Wealth Management's 13F filing for Q3 2024, filed 7 Nov 2024.